Refeeding Syndrome in Home-Initiated Parenteral Nutrition: A Review of Real-World Risks and Management Strategies

Jennifer Lachnicht, RD, CNSC; Christine Miller, PharmD; Jessica Younkman, RD, CNSC – Soleo Health

Background and Purpose

Since the 1990s, initiating parenteral nutrition (PN) at home has been performed, though some clinicians prefer hospital initiation due to risks like refeeding syndrome (RS). A key factor in successful home PN (HPN) initiation is careful evaluation by an experienced nutrition support clinician, particularly assessing RS risk. In 2020, ASPEN published consensus recommendations for identifying patients at risk for RS and guidelines for initiating and advancing nutrition.1 Home PN initiation offers advantages, including avoiding hospitalization, reducing healthcare costs, minimizing hospital-acquired infections, and improving quality of life. Literature suggests a savings of $2,000 per day when PN is started at home.2 This study aims to determine the risk and incidence of RS in patients who began PN at home, based on the 2020 ASPEN Consensus Recommendations for RS.

Key Findings

  • 40% of patients developed some form of refeeding syndrome post-HPN initiation
  • Only 16% experienced moderate to severe electrolyte drops despite 96% being classified as moderate to severe RS risk
  • 88.9% of patients experienced significant weight loss (average 22%) over 6-7 months
  • Post-feeding laboratory monitoring occurred on average 4.32 days after starting PN
  • Home PN initiation successfully avoided hospitalization in 92.5% of cases

Methods

ASPEN Figure 1

Results

ASPEN Figure 2

Research Objectives

This retrospective observational study was designed to:

  • Evaluate the safety profile of home-initiated parenteral nutrition
  • Determine the actual incidence of refeeding syndrome in home PN patients
  • Assess the effectiveness of ASPEN 2020 risk stratification guidelines
  • Analyze patient outcomes and success rates
  • Identify best practices for clinical monitoring and management

Study Population and Inclusion Criteria

Patient Demographics:

  • Study Period: September 2022 – June 2024
  • Total Patients: 27 individuals
  • Home PN Success Rate: 92.5% (25 patients successfully initiated)
  • Unable to Start: 7.5% (2 patients)

Baseline Patient Characteristics:

  • Average BMI: 19.6 kg/m²
  • BMI Range: 12.7-31.8 kg/m²
  • Median BMI: 18.9 kg/m²
  • High-Risk Comorbidities: 100% of patients
  • Reported Weight Loss: 88.9% of patients
  • Average Weight Loss: 22% over 6-7 months

Risk Stratification Protocol

Based on comprehensive pre-HPN assessment, patients were categorized using ASPEN criteria:
Refeeding Syndrome Risk Distribution:

  • Mild Risk: 4% of patients
  • Moderate Risk: 48% of patients
  • Moderate to Severe Risk: 11% of patients
  • Severe Risk: 37% of patients

Cumulative High-Risk Population: 96% of patients were classified as moderate to severe RS risk, highlighting the vulnerability of this patient population.

Clinical Monitoring Protocol

Pre-Initiation Assessment

  • Comprehensive nutritional evaluation within 5 days
  • Laboratory work completion: 96.2% within 5-day window
  • Pre-feeding electrolyte abnormalities identified in 18.5% of patients

Oral Intake Assessment

  • 92.3% had little to no oral intake
  • Intake quantified over 5-10 days prior to HPN assessment

ASPEN Figure 3

ASPEN Figure 4

Diagnostic Criteria Analysis

Criterion 1: Decrease in serum phosphorus, potassium, and/or magnesium levels

  • Mild RS (10-20% decrease): 24% of patients
  • Moderate RS (20-30% decrease): 8% of patients
  • Severe RS (>30% decrease): 8% of patients

Individual Electrolyte Analysis:

  • Potassium Deficiency: 4% mild RS, 0% moderate/severe
  • Magnesium Deficiency: 4% mild RS, 0% moderate/severe
  • Phosphorus Deficiency: 16% mild RS, 8% moderate, 8% severe

Overall Refeeding Syndrome Incidence: 40% of patients developed some category of RS

Criterion 2 Assessment:

Post-feeding laboratory monitoring was conducted on average 4.32 days after PN initiation, meeting the 5-day window requirement for RS diagnosis.

Treatment Success and Patient Outcomes
  • Home PN Initiation Success Rate: 92.5% (25 of 27 patients)
  • Patients Unable to Start (7.5%):

Patient 1: Persistently low pre-PN electrolyte levels despite IV repletion
Patient 2: Failed to meet home care admission criteria

Note: Nutritional assessments were conducted via phone for these patients, limiting comprehensive evaluation capabilities. One patient reported fat/muscle wasting, affecting assessment accuracy.

Weight Management Outcomes

  • 88.9% of patients experienced documented weight loss
  • Average weight loss: 22% over 6-7 months period
  • Weight loss likely contributed to malnutrition risk and RS susceptibility

Clinical Implications and Best Practices
Risk Mitigation Strategies

Pre-Initiation Protocol

  • Comprehensive nutritional assessment by certified nutrition support clinician
  • Laboratory evaluation within 5 days of planned start
  • Electrolyte repletion prior to PN initiation when indicated
  • Risk stratification using ASPEN 2020 guidelines

Formula Design Considerations

  • Conservative caloric initiation (10-20 kcal/kg/day)
  • Appropriate dextrose limitation (100-150 g/day)
  • Aggressive electrolyte supplementation based on risk assessment
  • Gradual advancement protocols

Monitoring Framework

  • Laboratory surveillance within 5 days of initiation
  • Clinical assessment for RS symptoms
  • Electrolyte trending and replacement protocols
  • Patient education and symptom recognition training
Clinical Decision-Making Framework

Ideal Candidates for Home PN Initiation

  • Patients with stable baseline electrolytes
  • Those meeting home care admission criteria
  • Individuals with adequate social support systems
  • Patients capable of emergency recognition and response

Relative Contraindications

  • Severely abnormal baseline electrolytes requiring IV correction
  • Inability to meet home care safety requirements
  • Limited access to emergency medical care
  • Inadequate social support or patient education capacity

Economic Impact and Healthcare Value

Direct Cost Savings

  • $2,000 per day savings compared to hospital initiation
  • Average home PN duration: Variable based on underlying condition
  • Projected annual savings for 25 successful patients: Substantial healthcare cost reduction

Indirect Benefits

  • Reduced hospital bed occupancy
  • Decreased healthcare-associated infection risk
  • Improved patient satisfaction scores
  • Enhanced family quality of life
  • Reduced caregiver burden and lost productivity

Quality Metrics and Patient Satisfaction

Clinical Quality Indicators

  • 92.5% successful home initiation rate
  • 40% RS incidence with effective management
  • 16% moderate-severe electrolyte disturbances (manageable with monitoring)
  • No reported serious adverse events requiring emergency intervention

Patient-Reported Outcomes

  • Improved comfort and dignity during treatment
  • Maintained family and social connections
  • Reduced anxiety associated with hospitalization
  • Enhanced sense of autonomy and control

Conclusion

Home initiation of PN can be safely implemented with careful monitoring and evaluation of RS risk. This study discovered 40% of patients were categorized as having some form of RS as identified through laboratory monitoring post-HPN initiation, highlighting the importance of clinical monitoring of this patient population by trained clinical dietitians. A small percentage (16%) of patients experienced moderate to severe drops in electrolytes – a relatively low incidence, considering 96% of patients were classified as moderate to severe risk of developing RS based on the assessment prior to HPN initiation. Close monitoring of labs and patient status, along with adherence to initial prescription recommendations, resulted in successful PN initiation at home in 92.5% of patients.

References

  1. Da Silva JSV, Seres DS, Sabino K, Adams SC, Berdahl GJ, Citty SW, et al. ASPEN Consensus Recommendations for Refeeding Syndrome. Nutr Clin Pract. 2020 Apr:35(2):178-195. doi: 10.1002/ncp.10474.
  2. Brown R, Haslehorst J, Cooper C, et al. Home Initiated Parenteral Nutrition is a Safe and Cost-Effective Approach to Nutrition Support. Am J Gastroenterol. 114:S684-S685, October 2019. doi: 10.14309/01.ajg.0000594436.43981.a3

Authors of this presentation disclose the following concerning possible financial or personal relationships with commercial entities that may have a direct or indirect interest in the subject matter of this presentation: Nothing to disclose.

Originally presented at ASPEN 2025 Nutrition Science & Practice Conference